virustomycin A: from Streptomyces sp. AM-2604
ID Source | ID |
---|---|
PubMed CID | 6441152 |
MeSH ID | M0112879 |
Synonym |
---|
concanamycin a, 23-o-de(4-o-(aminocarbonyl)-2,6-dideoxy-beta-d-arabino-hexopyranosyl)-23-o-(4-((2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino)-1,4-dioxo-2-butenyl)- |
antibiotic am-2604 a |
am-2604 a |
virustomycin a |
[(2r,4r,5s,6r)-2-[(2s,3r,4s)-4-[(3s,4z,6z,9r,10s,11s,12r,13r,14z,16e)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6,14,16-tetraen-2-yl]-3-hydroxypentan-2-yl]-2-hydroxy-5-methyl-6-[(z)-prop-1-enyl]oxan-4-yl] (e |
84777-85-5 |
am 2604a |
antibiotic am 2604a |
HB4122 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |